3-[6-(4H-imidazol-2-yl)-3-pyridinyl]-5-[(4-methoxycyclohexyl)methyl]-7,8-dihydropyrazino[2,3-b]pyrazin-6-one
C22H25N7O2 — CID 153181286
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[6-(4H-imidazol-2-yl)-3-pyridinyl]-5-[(4-methoxycyclohexyl)methyl]-7,8-dihydropyrazino[2,3-b]pyrazin-6-one
3-[6-(4H-imidazol-2-yl)-3-pyridinyl]-5-[(4-methoxycyclohexyl)methyl]-7,8-dihydropyrazino[2,3-b]pyrazin-6-one (PubChem CID 153181286) has the molecular formula C22H25N7O2 and a molecular weight of 419.49 g/mol. Its IUPAC name is 3-[6-(4H-imidazol-2-yl)-3-pyridinyl]-5-[(4-methoxycyclohexyl)methyl]-7,8-dihydropyrazino[2,3-b]pyrazin-6-one.
Molecular Properties
| Compound Name | 3-[6-(4H-imidazol-2-yl)-3-pyridinyl]-5-[(4-methoxycyclohexyl)methyl]-7,8-dihydropyrazino[2,3-b]pyrazin-6-one |
|---|---|
| PubChem CID | 153181286 |
| Molecular Formula | C22H25N7O2 |
| Molecular Weight | 419.49 g/mol |
| Exact Mass | 419.21 |
| IUPAC Name | 3-[6-(4H-imidazol-2-yl)-3-pyridinyl]-5-[(4-methoxycyclohexyl)methyl]-7,8-dihydropyrazino[2,3-b]pyrazin-6-one |
| SMILES | COC1CCC(CN2C(=O)CNc3ncc(-c4ccc(C5=NCC=N5)nc4)nc32)CC1 |
| InChI | InChI=1S/C22H25N7O2/c1-31-16-5-2-14(3-6-16)13-29-19(30)12-27-21-22(29)28-18(11-26-21)15-4-7-17(25-10-15)20-23-8-9-24-20/h4,7-8,10-11,14,16H,2-3,5-6,9,12-13H2,1H3,(H,26,27) |
| InChIKey | WGFGNQJRJGIWNE-UHFFFAOYSA-N |
| XLogP | 2.33 |
| TPSA | 104.96 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 419.49 |
| LogP ≤ 5 | 2.33 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153181286 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.